Neomycin inhibits glioma cell migration

Neurological Research

Volumn 26, Issue 3, 2004, Pages 273-275

  Cuevas, Pedro ^a,b   Díaz González, Diana ^a   Dujovny, Manuel ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glioma cells; Migration; Neomycin; Wound assay

Indexed keywords

NEOMYCIN;

ANIMAL CELL; ARTICLE; ASSAY; CANCER INHIBITION; CARCINOGENESIS; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; GLIOMA CELL; NONHUMAN; RAT; WOUND;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOMA; MICE; NEOMYCIN; PROTEIN SYNTHESIS INHIBITORS;

EID: 2442420205     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164104225013941     Document Type: Article

References (19)

1. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Molecular biology of the cell, 3rd edn, New York: Garland Publishing Inc., 1994: pp 721-785
2. Kulkarni NV, Gish G, van der Geer P, Henkemeyer M, Pawson T. Role of p120 Ras-GAP in directed cell movement. J Cell Biol 2000; 149: 457-470
3. Sharma G-D, He J, Bazan HEP. P38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing. J Biol Chem 2003; 278: 21989-21997
4. Pola S, Cattaneo MG, Vicentini LM. Antimigratory and anti-invasive effect of somatostatin in human neuroblastoma cells. Involvement of Rac and MAP kinase activity. J Biol Chem 2003; 278: 40601-40606
5. Chattopadhyay N, Tfeit-Hansen J, Brown EM. PKC, p42/44 MAPK and p38 MAPK regulate hepatocyte growth factor secretion from human astrocytoma. Cells Mol Brain Res 2002; 102: 73-82
6. Nagai S, Washiyama K, Kurimoto M, Takaki A, Endo S, Kumanishi T. Aberrant nuclear factor kB activity and its participation in the growth of human malignant astrocytoma. J Neurosurg 2002; 96: 909-917
7. Cano E, Mahadeven LC. Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 1995; 20: 117-122
8. Mercurio F, Manning AM. Multiple signals converging on NF-kB. Curr Opin Cell Biol 1999; 11: 226-232
9. Helbig G, Christopherson KW, Bhant-Nakshatsi P, et al. NF-kB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4 J Biol Chem 2003; 278: 21631-21638
10. Cuevas P, Díaz-González D, Carceller F, Dujovny M. Dual blockade of mitogen-activated protein kinases ERK-1 (p42) and ERK-2 (p44) and cyclic AMP response element binding protein (CREB) by neomycin inhibits glioma cell proliferation. Neurol Res 2003; 25: 13-16
11. Cuevas P, Díaz-González D, Dujovny M. Glioma cell-associated sustained activation of the transcription factor, nuclear factor-kB, was inhibited by neomycin. Neurol Res 2003; 25: 271-274
12. Hagedorn M, Zilberberg L, Lozano RM, et al. A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2. FASEB J 2001; 15: 550-552
13. Waterman-Storer CM, Salmon ED. Positive feedback interactions between microtubule and actin dynamics during cell motility. Curr Opin Cell Biol 1999; 11: 61-67
14. Martindale. The Extra Pharmacopoeia. Reynolds JEF, ed, London: The Pharmaceutical Press, 1989: pp. 268-269
15. Safiejki-Mroczka B, Bell PB. The induction of protrusion by neomycin in human gliomal cells is correlated with a decrease followed by an increase in filamentous actin. Cell Biol Int 1995; 19: 655-674
16. Hu G-F. Neomycin inhibits the angiogenic activity of fibroblast and epidermal growth factors. Biochem Biophys Res Commun 2001; 287: 870-874
17. Cuevas P, Díaz-González D, Dujovny M. Antiproliferative effect of neomycin in glioma cells. Neurol Res 2002; 224: 389-391
18. Cuevas P, Carceller F, Díaz-González D, C et al. Inhibition of rat glioma growth by neomycin. Preliminary report. Neurol Res 2002; 24: 522-524
19. Cuevas P, Díaz-González D, Dujovny M. Antiproliferative action of neomycin is associated with inhibition of cyclin D1 activation in glioma cells. Neurol Res 2003; 25: 691-693